Related Experiment Video
Updated: Apr 2, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Exploring The Multifaceted Medicinal Benefits of Phyllanthus niruri: Insights into Its Antiurolithic,
Vijishna Lekshmi Viswambharan1, Praveen Halagali2, Raagul Seenivasan2
1Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Abstract:
Phyllanthus niruri L., (p. niruri) commonly known as the 'Stone breaker plant', has been widely used worldwide as a typical remedy of nature for a long time, for the treatment of kidney health and urinary diseases mainly. According to the given ethnomedicine and traditional uses of the herb, it can have various therapeutic applications for classes of human diseases. This exhaustive review first of all concentrates on the food values, phytochemical profile, antidiabetic, antiurolithic, hepatoprotective activities, and formulation studies, and also checks the safety, toxicity, and clinical trials of P. niruri. P. niruri has yielded a total of 120 phytoconstituents. The major biologically active compounds identified are alkaloids, tannins, coumarins, sterols, phenolic acid, flavonoids, and lignans. These compounds are the major reason for the huge pharmacological activities of the plant, which comprise antiviral, immunomodulatory, hepatoprotective, antidiabetic, antiurolithic, anti-inflammatory, antibacterial, anticancer, antifungal, and tranquilizing effects. P. niruri highlights a wonderful perspective, especially with its antidiabetic, antiurolithic, and hepatoprotective properties, showing its potential application in future therapy regimens. In multiple clinical trials, P. niruri remains a treatment option of great value for patients irrespective of their ages, and additionally, it is a safe and efficacious alternative.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Epiphytes, Parasites, and Carnivores

